Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.

Abelson MB, Gomes PJ.

Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):453-61. doi: 10.1517/17425255.4.4.453 . Review.

PMID:
18433347
2.

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.

Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G; International Olopatadine Study Group.

Clin Ther. 2002 Oct;24(10):1561-75.

PMID:
12462286
3.

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.

Mah FS, O'Brien T, Kim T, Torkildsen G.

Curr Med Res Opin. 2008 Feb;24(2):441-7. doi: 10.1185/030079908X261078 .

PMID:
18167176
4.

A review of olopatadine for the treatment of ocular allergy.

Abelson MB.

Expert Opin Pharmacother. 2004 Sep;5(9):1979-94. Review.

PMID:
15330735
6.

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

Leonardi A, Quintieri L.

Expert Opin Pharmacother. 2010 Apr;11(6):969-81. doi: 10.1517/14656561003694643. Review.

PMID:
20307221
8.

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.

Rosenwasser LJ, O'Brien T, Weyne J.

Curr Med Res Opin. 2005 Sep;21(9):1377-87. Review.

PMID:
16197656
11.
12.

Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.

Fujishima H, Ohashi Y, Takamura E.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):476-81. doi: 10.1016/j.anai.2014.07.007. Epub 2014 Aug 20.

PMID:
25163405
14.

Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis.

Shimura M, Yasuda K, Miyazawa A, Otani T, Nakazawa T.

Am J Ophthalmol. 2011 Apr;151(4):697-702.e2. doi: 10.1016/j.ajo.2010.10.001. Epub 2011 Jan 22.

PMID:
21257151
15.
17.

Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.

Lanier BQ, Gross RD, Marks BB, Cockrum PC, Juniper EF.

Ann Allergy Asthma Immunol. 2001 Jun;86(6):641-8.

PMID:
11428736
18.

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.

Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL.

Curr Med Res Opin. 2004 Aug;20(8):1227-33.

PMID:
15324525

Supplemental Content

Support Center